Page last updated: 2024-11-08

aurone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth
FloraRankFlora DefinitionFamilyFamily Definition
UvariagenusA plant genus of the family ANNONACEAE. Members contain uvarigrin, uvarigrandin, chamuvaritin and other acetogenins and benzylisoquinoline alkaloids.[MeSH]AnnonaceaeThe custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.[MeSH]

Cross-References

ID SourceID
PubMed CID6537099
CHEMBL ID1315175
CHEBI ID47964
SCHEMBL ID305100
MeSH IDM0467103

Synonyms (16)

Synonym
CMLD3_000104
NCGC00090520-01
(2z)-2-benzylidene-1-benzofuran-3-one
STL169317
(2z)-2-benzylidene-1-benzofuran-3(2h)-one
AKOS005367133
582-04-7
aurone ,
CHEBI:47964 ,
SCHEMBL305100
(z)-aurone
CHEMBL1315175
2-benzylidene-coumaran-3-one
2-benzylidene-3(2h)-benzofuranone
2-[(z)-1-phenylmethylidene]-1-benzofuran-3-one
2-benzylidenebenzofuran-3(2h)-one

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
cyclic ketone
auronesAny member of the class of 1-benzofurans with an arylmethylidene substituent at position 2. The term was originally restricted to natural products, but is now also used to describe semi-synthetic and fully synthetic compounds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency3.54810.003245.467312,589.2998AID2517
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase 17BHomo sapiens (human)IC50 (µMol)24.64000.02582.20726.2000AID1446693
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
protein phosphorylationSerine/threonine-protein kinase 17BHomo sapiens (human)
apoptotic processSerine/threonine-protein kinase 17BHomo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase 17BHomo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase 17BHomo sapiens (human)
positive regulation of fibroblast apoptotic processSerine/threonine-protein kinase 17BHomo sapiens (human)
positive regulation of apoptotic processSerine/threonine-protein kinase 17BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
protein kinase activitySerine/threonine-protein kinase 17BHomo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase 17BHomo sapiens (human)
ATP bindingSerine/threonine-protein kinase 17BHomo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase 17BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleusSerine/threonine-protein kinase 17BHomo sapiens (human)
nucleoplasmSerine/threonine-protein kinase 17BHomo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentSerine/threonine-protein kinase 17BHomo sapiens (human)
plasma membraneSerine/threonine-protein kinase 17BHomo sapiens (human)
actin cytoskeletonSerine/threonine-protein kinase 17BHomo sapiens (human)
Flemming bodySerine/threonine-protein kinase 17BHomo sapiens (human)
nucleusSerine/threonine-protein kinase 17BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1819030Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1819032Antiproliferative activity against human KB cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1601690Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 18 to 24 hrs in aerobic condition by two-fold serial dilutions method2019European journal of medicinal chemistry, Mar-01, Volume: 165Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens.
AID1143190Selectivity index, ratio of EC50 for HEK293T cells to IC50 for chloroquine-resistant ring stage Plasmodium falciparum W22014European journal of medicinal chemistry, Jun-10, Volume: 80Probing the aurone scaffold against Plasmodium falciparum: design, synthesis and antimalarial activity.
AID1090554Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves assessed as leaf disk consumed at 0.33 mg/cm2 at 26.5 degC2007Journal of agricultural and food chemistry, Feb-07, Volume: 55, Issue:3
Synthesis and insect antifeedant activity of aurones against Spodoptera litura larvae.
AID1143188Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum W2 infected in human RBC after 48 hrs by flow cytometric analysis2014European journal of medicinal chemistry, Jun-10, Volume: 80Probing the aurone scaffold against Plasmodium falciparum: design, synthesis and antimalarial activity.
AID1329701Inhibition of butyrylcholinesterase (unknown origin) using butyrylthiocholine chloride as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis2017Bioorganic & medicinal chemistry, 01-01, Volume: 25, Issue:1
Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
AID1090556Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves assessed as leaf disk consumed at 26.5 degC2007Journal of agricultural and food chemistry, Feb-07, Volume: 55, Issue:3
Synthesis and insect antifeedant activity of aurones against Spodoptera litura larvae.
AID1446693Inhibition of recombinant GST-tagged DRAK2 (unknown origin) autophosphorylation after 2 hrs by ADP-glo assay2017European journal of medicinal chemistry, Apr-21, Volume: 130Discovery of benzofuran-3(2H)-one derivatives as novel DRAK2 inhibitors that protect islet β-cells from apoptosis.
AID1143197Inhibition of Plasmodium falciparum falcipain-2 up to 50 uM2014European journal of medicinal chemistry, Jun-10, Volume: 80Probing the aurone scaffold against Plasmodium falciparum: design, synthesis and antimalarial activity.
AID1329700Inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition measured after 20 mins by UV-Vis spectrophotometric analysis2017Bioorganic & medicinal chemistry, 01-01, Volume: 25, Issue:1
Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
AID1819031Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1601691Antimicrobial activity against Pseudomonas aeruginosa after 18 to 24 hrs in aerobic condition by two-fold serial dilutions method2019European journal of medicinal chemistry, Mar-01, Volume: 165Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens.
AID1819029Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1143189Cytotoxicity against HEK293T cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Jun-10, Volume: 80Probing the aurone scaffold against Plasmodium falciparum: design, synthesis and antimalarial activity.
AID1819033Antiproliferative activity against human KB-VIN cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (13.76)29.6817
2010's74 (67.89)24.3611
2020's20 (18.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (5.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other104 (94.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]